Do Essential Oils Work? Reviewing the Evidence on Antiviral Claims, Aromatherapy, and Endocrine Concerns in Children

Benefits and Risks of Essential Oils: What Does the Human Evidence Show?

The conclusion in one sentence

Essential oils can affect scent perception and subjective experience, and aromatherapy may offer limited help with anxiety or sleep. At present, however, in vitro antiviral findings, images of red blood cells, and isolated case reports cannot be treated as direct proof that essential oils prevent infection, cure disease, or inevitably cause endocrine disorders.（PMID: 32756359；PMID: 31655395；PMID: 38187077）

First distinguish “biologically active” from “effective in humans”

A common misunderstanding in essential-oil research is to take antibacterial, antiviral, or receptor activity observed in a laboratory and assume that inhaling or applying the oil will prevent disease. Observations in cells, chemical mechanisms, or air environments can provide research leads, but no more than that. The dose, route of exposure, metabolism, and clinical endpoints in humans are different, so clinical validation cannot be skipped. Existing reviews indicate that most antiviral evidence remains preclinical, with little clinical data; it is not sufficient to classify essential oils as a way to prevent respiratory infections or as a standard treatment.（PMID: 32756359）

Professor Ching-Shun Lin’s original article opposed marketing essential oils as a disease-prevention tool, and that central warning remains consistent with the direction of current evidence. The literature has since evolved: human nebulization trials have indeed appeared, so “there has been no human research at all” no longer accurately describes the literature today. Yet the early trial did not establish viral clearance, infection prevention, or a direct antiviral benefit. It therefore cannot be used to prove that smelling essential oils prevents infection.（PMID: 35813974；PMID: 39861359）

Anxiety and sleep: Possible benefits, but they should not be overstated

Aromatherapy research on anxiety and sleep includes some positive findings, but the interventions, participant populations, and assessment methods vary across studies. The results may also be affected by bias and the limited number of studies. The more defensible conclusion is that aromatherapy “may improve the subjective experience of some people,” not that it has been proven to treat anxiety disorders, insomnia, or other diseases. Comfort from the scent, expectations, and the setting in which care is provided may all contribute to the observed effect.（PMID: 31655395；PMID: 41393037）

Routes of administration also need to be redefined in light of today’s literature. Studies do include inhalation, so the claim that essential oils “must only be applied topically” does not reflect the current research landscape. This is a refinement in scope brought about by scientific progress; it does not mean that inhalation has been proven to treat disease, nor does it mean that every product and method of use has the same effect.（PMID: 36687893；PMID: 31655395）

Oils on the soles and red blood cell arrangement: Images are not proof of efficacy

A claim that applying a blend of essential oils to the soles rapidly changes the arrangement of red blood cells and thereby demonstrates a beneficial therapeutic effect would require, at minimum, reproducible controlled studies, clearly defined testing procedures, and clinical outcomes. This evidence review found no study supporting that causal chain. Differences between before-and-after video images cannot rule out sampling, slide preparation, observation conditions, or natural variation, and they cannot substitute for an efficacy trial. The appropriate assessment is “insufficient evidence,” not a finding of effectiveness based solely on images that look different.

Bach flower remedies: No reliable evidence of benefit beyond placebo

Bach flower remedies are often promoted for anxiety, attention problems, pain, and other psychological distress. Systematic reviews, however, have found no reliable and reproducible therapeutic effect superior to placebo, while evidence relating to pain is also insufficient. This does not mean that users’ experiences are imaginary. It means that current trials cannot show that those effects arise from a specific action of the flower remedies themselves.（PMID: 20734279；PMID: 19470153）

Safety likewise calls for cautious language. A review offered the provisional assessment that these remedies “may be safe,” but adverse-event reporting was incomplete and the overall body of data was small. “No clear signal at present” therefore cannot be upgraded to “safety has been adequately established.”（PMID: 19470153）

Lavender, tea tree oil, and breast development in children

Cases of prepubertal gynecomastia or premature breast development following topical exposure to lavender or tea tree oil have indeed been reported. In vitro studies have also observed estrogen-like or antiandrogen-like activity in some constituents. These findings warrant continued investigation, but case reports and in vitro signals alone cannot establish that the product caused the condition.（PMID: 32147050；PMID: 31393563）

A more recent review states explicitly that the limited case reports and in vitro findings remain insufficient to establish causation. In other words, the evidence currently supports saying that “a possible risk remains to be clarified,” not that any exposure will cause an endocrine disorder in a child.（PMID: 38187077）

The literature has also examined individual constituents more precisely. Newer guideline-based testing of linalool and linalyl acetate, major constituents of lavender, did not confirm estrogenic activity. This negative result applies only to the specific constituents and conditions tested, however; it cannot be generalized in reverse to claim that every essential oil, formulation, or route of exposure is risk-free.（PMID: 37906319）

How to assess claims without being led by marketing

When you encounter a claim about the benefits of an essential oil, first ask: Does the evidence come from a test tube, an animal experiment, a case report, or a controlled human trial? Did the study measure a transient sensation, a laboratory marker, or an actual improvement in disease? Are the product, method of use, and research conditions the same? If any link in that chain differs, the study’s conclusion cannot simply be transferred to a commercial product.

The enduring point of Professor Lin’s original article is its reminder not to mistake media videos, in vitro mechanisms, or marketing language for clinical evidence. A current reassessment should preserve that methodological warning while candidly identifying where the literature has advanced: early human research now exists, but prevention has not been demonstrated; inhalation has been studied, but that does not mean inhalation treats disease; and case reports and in vitro signals exist, but a causal link to endocrine effects in children has not been established.（PMID: 35813974；PMID: 36687893；PMID: 38187077）